A Discussion with Brian Finn of Findell Capital: Biotech Investing, Liquidia & ProQR Encode Ideas: Plainspoken Biotech and Medtech Interviews

An interview with Brian Finn of Findell Capital, where we discuss his perspective on small-cap investing.  During the interview, we discuss two of Brian's favorite health care names, Liquidia and ProQR, as well as his previous success with MiMedx.  To learn more about Findell Capital please visit their website https://findell.us/
Companies discussed during the podcast;
Liquidia Corporation (Nasdaq: LQDA)
ProQR Therapeutics N.V. (Nasdaq: PRQR)
MiMedx Group Inc (Nasdaq: MDXG)
United Therapeutics Corporation (Nasdaq: UTHR)
MannKind Corporation (Nasdaq: MNKD)
Editas Medicine Inc (Nasdaq: EDIT)